$18.770
-0.629 (-3.35%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RLAY por análisis de gráficos similares
Alphio's RLAY stock price prediction model matches the current Relay Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.82 (+0.27%). The 1-week path is $18.57 (-1.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Relay Therapeutics Inc?
Relay Therapeutics Inc is a good buy right now due to its current price of $18.77, which is significantly below analyst price targets of $29 and $31, indicating potential upside. Additionally, the company has a robust gross margin of 100% and a strong year-to-date change of +129.46%, reflecting its growth potential despite recent insider selling. The main risk is the negative net income, which stands at -83,707,000 USD for Q2 2026, indicating ongoing financial challenges.
RLAY cerró en $18.77 el Friday, tras bajar -3.35%
Relay Therapeutics Inc (RLAY) last closed at $18.77, losing -3.35%. These facts feed the 1-day and 1-week RLAY price prediction above.
Factores de la previsión
Los factores de la previsión de Relay Therapeutics Inc (RLAY) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RLAY, ordenadas por similitud.
Análisis de estacionalidad de RLAY
Historically the probability of a positive August return for RLAY is 31.75%. December offers the highest probability of a positive month at 51.16%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.